Aspen Neuroscience, Inc.
live · Yahoo FinanceLimited buying: $68.0M bought (counted up to $5.0M); 4 distinct insiders. Holding it back: largest buyer: Thompson Peter A. (Director), 29% of the dollars.
AI summary Venture backers OrbiMed and ARCH buy $35M in Aspen Neuroscience's $15/share IPO
Score, not a recommendation.
partial dataAn input is missing, usually the market cap or the price history. A missing input counts as neutral in the score and is never estimated. Market cap is missing; missing inputs count as neutral in the score.
same price, one day All 6 purchases were at $15.00 on 2026-11-02. That pattern also occurs in IPO or conversion subscriptions, which are not open-market conviction buying.
Price and insider purchases
Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.
Loading price history…
How the score adds up
How each input is counted →| Input | Strength | Points |
|---|---|---|
| $68.0M bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. | 100% | +57 |
| 4 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. | 60% | +9 |
| No CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. | 0% | +0 |
| Stock 0% below its 1-year highHow far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. | 0% | +0 |
| 0 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. | 100% | +0 |
| Routine or plan purchases: 0% of the dollars | 100% | +0 |
| Largest buyer: Thompson Peter A. (Director), 29% of the dollars | 94% | -4 |
| Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast. | 62 | |
| AI adjustmentPoints added or taken off by a language model that reads the SEC filings and recent news about the cluster and classifies the buying (for example open market, plan or offering). It can be wrong, it is shown as its own line, and it is never used in past results. | -14 | |
| Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. | 48 | |
Why are they buying?
AI · ipo_offering · catalyst credible · documentedThe purchases occurred on November 2, 2026, the closing date of Aspen Neuroscience's $140.6 million initial public offering of 9,375,000 shares priced at $15.00 per share. Form 4 footnotes confirm that the shares were acquired directly in the IPO alongside the automatic conversion of existing preferred stock upon closing.
With overlapping beneficial ownership reports removed, OrbiMed Private Investments VII bought 1,000,000 shares ($15.0 million) and ARCH Venture funds bought 1,333,333 shares ($20.0 million), representing about a quarter of the offering. The stock began trading on October 30, 2026, closing its debut at $14.89, and neither group has any other Form 4 purchases or sales over the prior three years.
Filing references and sources
- Form 4 - ORBIMED ADVISORS LLC (opens in a new tab)
- Form 4 - Thompson Peter A. (opens in a new tab)
- Form 4 - BERNS PAUL L (opens in a new tab)
- Form 4 - CRANDELL KEITH (opens in a new tab)
- Form 8-K (2026-11-02) (opens in a new tab)
- Aspen Neuroscience Announces Pricing of Initial Public Offering | Morningstar (opens in a new tab)
- Aspen Neuroscience IPO slips below $15 (opens in a new tab)
| Date | InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. | Role | Shares | Price | Value | Flags | Filing |
|---|---|---|---|---|---|---|---|
| 2026-11-02 | CRANDELL KEITH history of CRANDELL KEITH's purchases | 10% owner | 1,333,333 | $15.00 avg | $20.0M | ||
| 2026-11-02 | CRANDELL KEITH | 66,666 | $15.00 | $1,000.0K | SEC filing for CRANDELL KEITH (opens in a new tab) | ||
| 2026-11-02 | CRANDELL KEITH | 66,667 | $15.00 | $1.0M | SEC filing for CRANDELL KEITH (opens in a new tab) | ||
| 2026-11-02 | CRANDELL KEITH | 1,200,000 | $15.00 | $18.0M | SEC filing for CRANDELL KEITH (opens in a new tab) | ||
| 2026-11-02 | BERNS PAUL L history of BERNS PAUL L's purchases | 10% owner | 1,200,000 | $15.00 | $18.0M | SEC filing for BERNS PAUL L (opens in a new tab) | |
| 2026-11-02 | ORBIMED ADVISORS LLC history of ORBIMED ADVISORS LLC's purchases | Director | 1,000,000 | $15.00 | $15.0M | SEC filing for ORBIMED ADVISORS LLC (opens in a new tab) | |
| 2026-11-02 | Thompson Peter A. history of Thompson Peter A.'s purchases | Director | 1,000,000 | $15.00 | $15.0M | SEC filing for Thompson Peter A. (opens in a new tab) | |
| Total | $68.0M | ||||||
What happened next
A buying runPurchases at one company with no pause longer than the cluster rule allows. A long pause ends the run, so one company can have several. ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmarkThe index a stock's return is compared with: a small-cap index for small companies, a large-cap index otherwise. (IWM for small companies, SPY otherwise), from the first open after the buying run became a cluster. Past results, not a forecast.
After this buying run became a cluster, vs benchmark: 21 days –63 days –126 days –